116 related articles for article (PubMed ID: 22856151)
21. [Investigation of Triazavirin antiviral activity against tick-borne encephalitis pathogen in cell culture].
Loginova SIa; Borisevich SV; Rusinov VL; Ulomskiĭ UN; Charushin VN; Chupakhin ON
Antibiot Khimioter; 2014; 59(1-2):3-5. PubMed ID: 25051708
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
Zarubaev VV; Golod EL; Anfimov PM; Shtro AA; Saraev VV; Gavrilov AS; Logvinov AV; Kiselev OI
Bioorg Med Chem; 2010 Jan; 18(2):839-48. PubMed ID: 20006516
[TBL] [Abstract][Full Text] [Related]
23. [Rimantadine and arbidol sensitivity of influenza viruses that caused epidemic morbidity rise in Russia in the 2004-2005 season].
Burtseva EI; Shevchenko ES; Leneva IA; Merkulova LN; Oskerko TA; Shliapnikova OV; Zaplatnikov AL; Shuster AM; Slepushkin AN
Vopr Virusol; 2007; 52(2):24-9. PubMed ID: 17500235
[TBL] [Abstract][Full Text] [Related]
24. Uncoating of a rimantadine-resistant variant of influenza virus in the presence of rimantadine.
Bukrinskaya AG; Vorkunova NK; Pushkarskaya NL
J Gen Virol; 1982 May; 60(Pt 1):61-6. PubMed ID: 7097251
[TBL] [Abstract][Full Text] [Related]
25. No-Spa and Remantadin are the novel complex preparations that inhibit effectively reproduction of the avian influenza viruses.
Zhilinskaya IN; Konovalova NI; Kiselev OI; Ashmarin IP
Dokl Biol Sci; 2007; 414():249-50. PubMed ID: 17668635
[No Abstract] [Full Text] [Related]
26. [The rimantadine sensitivity spectrum in influenza A viruses circulating in the 2002-2004 epidemic seasons].
Shevchenko ES; Burtseva EI; Slepushkin AN; Merkulova LN; Gatich RZ; Ivanova VT; Oskerko TA
Vopr Virusol; 2005; 50(5):32-5. PubMed ID: 16250597
[TBL] [Abstract][Full Text] [Related]
27. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N
Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of activity against influenza viruses by combinations of antiviral agents.
Hayden FG; Douglas RG; Simons R
Antimicrob Agents Chemother; 1980 Oct; 18(4):536-41. PubMed ID: 7447417
[TBL] [Abstract][Full Text] [Related]
29. Influenza virus uncoating in infected cells and effect of rimantadine.
Bukrinskaya AG; Vorkunova NK; Kornilayeva GV; Narmanbetova RA; Vorkunova GK
J Gen Virol; 1982 May; 60(Pt 1):49-59. PubMed ID: 7097250
[TBL] [Abstract][Full Text] [Related]
30. Low incidence of rimantadine resistance in field isolates of influenza A viruses.
Ziegler T; Hemphill ML; Ziegler ML; Perez-Oronoz G; Klimov AI; Hampson AW; Regnery HL; Cox NJ
J Infect Dis; 1999 Oct; 180(4):935-9. PubMed ID: 10479115
[TBL] [Abstract][Full Text] [Related]
31. Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
Sasaki-Tanaka R; Shibata T; Moriyama M; Okamoto H; Kogure H; Kanda T
J Virol; 2022 Sep; 96(18):e0064622. PubMed ID: 36040176
[TBL] [Abstract][Full Text] [Related]
32. [Effect of ribovirine (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboximide) on RNA-dependent RNA-polymerase induction and virus-specific polysome formation in cell cultures infected with influenza A virus].
Linitskaia GL; Iatsyna AA; Pushkarskaia NL; Galegov GA
Vopr Med Khim; 1978; 24(5):699-702. PubMed ID: 568351
[No Abstract] [Full Text] [Related]
33. Are the 2-isomers of the drug rimantadine active anti-influenza A agents?
Zoidis G; Kolocouris N; Foscolos GB; Kolocouris A; Fytas G; Karayannis P; Padalko E; Neyts J; De Clercq E
Antivir Chem Chemother; 2003 May; 14(3):153-64. PubMed ID: 14521332
[TBL] [Abstract][Full Text] [Related]
34. Application of an In-Cell Western assay for measurement of influenza A virus replication.
Wan Y; Zhou Z; Yang Y; Wang J; Hung T
J Virol Methods; 2010 Nov; 169(2):359-64. PubMed ID: 20709106
[TBL] [Abstract][Full Text] [Related]
35. Heterocyclic rimantadine analogues with antiviral activity.
Stamatiou G; Foscolos GB; Fytas G; Kolocouris A; Kolocouris N; Pannecouque C; Witvrouw M; Padalko E; Neyts J; De Clercq E
Bioorg Med Chem; 2003 Dec; 11(24):5485-92. PubMed ID: 14642592
[TBL] [Abstract][Full Text] [Related]
36. [Comparative study of the action of amantadine (1-aminoadamantane) and remantadine (alpha-methyl-1-adamantane methylamine) hydrochloride on influenza virus A reproduction].
Vladyko AS; Shobukhov VM
Vopr Virusol; 1981; (3):366-7. PubMed ID: 7293168
[No Abstract] [Full Text] [Related]
37. [Investigation of Therapeutic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice].
Loginova SY; Borisevich SV; Rusinov VL; Ulomsky EN; Charushin VN; Chupakhin ON; Sorokin PV
Antibiot Khimioter; 2015; 60(7-8):11-3. PubMed ID: 26863736
[TBL] [Abstract][Full Text] [Related]
38. [Investigation of susceptibility of influenza viruses A (H1N1), the cause of infection in humans in April-May 2009, to antivirals in MDCK cell culture].
Romanovskaia AA; Durymanov AM; Sharshov KA; Zaĭkovskaia AV; Susloparov IM; Shestopalov AM; Leneva IA; Drozdov IG
Antibiot Khimioter; 2009; 54(5-6):41-7. PubMed ID: 20052917
[TBL] [Abstract][Full Text] [Related]
39. Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets.
Sweet C; Hayden FG; Jakeman KJ; Grambas S; Hay AJ
J Infect Dis; 1991 Nov; 164(5):969-72. PubMed ID: 1940477
[TBL] [Abstract][Full Text] [Related]
40. [Change in the influenza virus upon multiplication in the presence of high concentrations of remantadine].
Karako NI; Boreko EI; Kirillov VA; Votiakov VI
Vopr Virusol; 1989; 34(1):43-6. PubMed ID: 2728406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
